UPDATED May 21, 2025
Discover U.S. Pharmaceuticals & Biotech Growth Stocks that are on the NYSE and NASDAQ. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
NRXP | US$2.63 | 15.9% | -32.6% | US$47.0m | US$31.67 | PE-1.8x | E166.9% | n/a | ||
PRPH | US$0.29 | -22.0% | -94.4% | US$13.7m | US$13.80 | PS2.1x | E136.3% | 0% | ||
AZTA | US$27.48 | 2.0% | -46.1% | US$1.3b | US$41.60 | PS1.9x | E124.5% | 0% | ||
MLAB | US$111.97 | -6.8% | -2.1% | US$626.6m | US$141.67 | PS2.6x | E121.2% | 0.6% | ||
BHC | US$4.48 | -1.8% | -29.7% | US$1.7b | US$7.08 | PE-41.4x | E112.5% | n/a | ||
EVOK | US$3.45 | 9.6% | -36.2% | US$6.5m | US$18.00 | PB1.2x | E102.4% | n/a | ||
ORGO | US$3.01 | 0% | 6.7% | US$413.5m | US$6.25 | PB1.6x | E101.0% | n/a | ||
SAVA | US$2.05 | 9.0% | -90.7% | US$108.2m | n/a | PB0.8x | E95.6% | n/a | ||
AMRX | US$7.27 | -1.1% | 9.3% | US$2.3b | US$11.67 | PE-174.6x | E93.3% | 0% | ||
TLRY | US$0.43 | -1.9% | -76.7% | US$452.7m | US$1.29 | PB0.2x | E90.0% | n/a | ||
EXAS | US$56.89 | 3.7% | 6.4% | US$10.9b | US$68.83 | PS3.8x | E88.9% | n/a | ||
HROW | US$26.73 | 6.4% | 55.2% | US$1.0b | US$52.05 | PS4.6x | E87.1% | n/a | ||
HBIO | US$0.33 | -5.7% | -90.1% | US$14.9m | US$3.00 | PB1x | E85.6% | n/a | ||
YCBD | US$0.91 | -7.3% | -84.0% | US$732.0k | US$16.00 | PB1.1x | E84.1% | n/a | ||
VTRS | US$8.48 | 0.7% | -22.0% | US$10.4b | US$11.75 | PB0.6x | E78.6% | 5.7% | ||
PLX | US$1.71 | 2.4% | 32.6% | US$136.9m | US$14.00 | PE34.8x | E78.1% | n/a | ||
IGMS | US$1.18 | 3.5% | -89.7% | US$74.5m | US$1.88 | PS26.5x | E73.4% | n/a | ||
OCGN | US$0.83 | 19.5% | -51.7% | US$236.5m | US$6.50 | PS53.6x | E73.0% | n/a | ||
IGC | US$0.32 | 11.7% | -38.4% | US$25.7m | US$3.88 | PS20.9x | E72.8% | n/a | ||
TEM | US$58.14 | -10.3% | n/a | US$10.8b | US$65.50 | PS12.5x | E72.1% | n/a | ||
PCSA | US$0.24 | 3.0% | -86.9% | US$1.3m | US$6.00 | PB0.4x | E71.9% | n/a | ||
MDXH | US$2.09 | 17.4% | -24.5% | US$106.9m | US$5.64 | PS1.1x | E70.0% | n/a | ||
OMER | US$3.11 | -20.9% | -9.1% | US$192.8m | US$36.00 | PE-1x | E69.6% | n/a | ||
SRRA | US$54.99 | 0.06% | 179.4% | US$1.3b | US$55.00 | PB5.1x | E69.5% | n/a |